[1]
|
步宏, 李一雷. 病理学[M]. 第9版. 北京: 人民卫生出版社, 2018: 329-330.
|
[2]
|
Rosińska, S. and Gavard, J. (2021) Tumor Vessels Fuel the Fire in Glioblastoma. International Journal of Molecular Sciences, 22, 6514. https://doi.org/10.3390/ijms22126514
|
[3]
|
Wen, P.Y. and Reardon, D.A. (2016) Progress in Glioma Diagnosis, Classification and Treatment. Nature Reviews Neurology, 12, 69-70. https://doi.org/10.1038/nrneurol.2015.242
|
[4]
|
Kang, S., Kwon, H.N., Kang, S., et al. (2020) Interaction between IDH1 WT and Calmodulin and Its Implications for Glioblastoma Cell Growth and Migration. Biochemical and Biophys-ical Research Communications, 524, 224-230.
https://doi.org/10.1016/j.bbrc.2020.01.073
|
[5]
|
Liang, H.-W., Luo, B., Du, L.-H., He, R.-Q., Chen, G., Peng, Z.-G. and Ma, J. (2019) Expression Significance and Potential Mechanism of Hypoxia-Inducible Factor 1 Alpha in Patients with Myelodysplastic Syndromes. Cancer Medicine, 8, 6021-6035. https://doi.org/10.1002/cam4.2447
|
[6]
|
Cen, L., Liu, R., Liu, W., et al. (2021) Competing Endogenous RNA Networks in Glioma. Frontiers in Genetics, 12, Article 675498. https://doi.org/10.3389/fgene.2021.675498
|
[7]
|
Huang, J., Yu, J., Tu, L., Huang, N., Li, H. and Luo, Y. (2019) Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development. Frontiers in Oncology, 9, 506. https://doi.org/10.3389/fonc.2019.00506
|
[8]
|
Vallée, A., Lecarpentier, Y. and Vallée, J.N. (2021) Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classifi-cation. Biomedicines, 9, 619.
https://doi.org/10.3390/biomedicines9060619
|
[9]
|
Sun, C., Zhao, Y., Shi, J., Zhang, J., Yuan, Y., Gu, Y., Zhang, F., Gao, X., Wang, C., Wang, Y., Wang, Z., Hu, P., Qin, J., Xiao, L., Chang, T., Wang, L., Xi, Y., Yin, H., Chen, H., Zhang, L., Cheng, G., Lin, J., Zhang, M., Li, Z. and Ye, J. (2019) Isocitrate Dehydrogenase 1 Mutation Reduces the Per-icyte Coverage of Microvessels in Astrocytic Tumours. Journal of Neuro-Oncology, 143, 187-196. https://doi.org/10.1007/s11060-019-03156-5
|
[10]
|
Bledea, R., Vasudevaraja, V., Patel, S., Stafford, J., Serrano, J., Esposito, G., Tredwin, L.M., Goodman, N., Kloetgen, A., Golfinos, J.G., Zagzag, D., Weigelt, B., Iafrate, A.J., Sulman, E.P., Chi, A.S., Dogan, S., Reis-Filho, J.S., Chiang, S., Placantonakis, D., Tsirigos, A. and Snuderl, M. (2019) Func-tional and Topographic Effects on DNA Methylation in IDH1/2 Mutant Cancers. Scientific Reports, 9, Article No. 16830. https://doi.org/10.1038/s41598-019-53262-7
|
[11]
|
Groblewska, M., Litman-Zawadzka, A. and Mroczko, B. (2020) The Role of Selected Chemokines and Their Receptors in the Development of Gliomas. International Journal of Molecu-lar Sciences, 21, 3704.
https://doi.org/10.3390/ijms21103704
|
[12]
|
Feng, R., Morine, Y., Ikemoto, T., Imura, S., Iwahashi, S., Saito, Y. and Shimada, M. (2018) Nrf2 Activation Drive Macrophages Polarization and Cancer Cell Epithelial-Mesenchymal Transition during Interaction. Cell Commun Signal, 16, 54. https://doi.org/10.1186/s12964-018-0262-x
|
[13]
|
Yang, C. (2021) D-2-Hydroxyglutarate in Glioma Biology. Cells, 10, 2345. https://doi.org/10.3390/cells10092345
|
[14]
|
Gatto, L., Franceschi, E., Tosoni, A., et al. (2021) IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment. Molecular Diagnosis & Therapy, 25, 457-473. https://doi.org/10.1007/s40291-021-00537-3
|
[15]
|
Fatima, S., Mounir, O., El Mehdi, H. and Majdouline, O. (2022) Immunohistochemical Expression of HIF-1α, IDH1 and TP53: Prognostic Profile of Moroccan Patients with Diffuse Glioma. Journal of Chemical Neuroanatomy, 119, Article 102056. https://doi.org/10.1016/j.jchemneu.2021.102056
|
[16]
|
Shimizu, T., Kurozumi, K., Ishida, J., et al. (2016) Adhesion Molecules and the Extracellular Matrix as Drugtargets for Glioma. Brain Tumor Pathology, 33, 97-106. https://doi.org/10.1007/s10014-016-0261-9
|
[17]
|
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J.C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M.A. and Alvarez-Sánchez, M.E. (2019) Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Frontiers in Oncology, 9, 1370. https://doi.org/10.3389/fonc.2019.01370
|
[18]
|
Su, L., Zhang, X., Zheng, L., et al. (2020) Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism. Frontiers in Endocrinology, 11, 189.
https://doi.org/10.3389/fendo.2020.00189
|
[19]
|
Hua, X., Yin, S.C., By, C., et al. (2020) Androgen Receptor Re-verses the Oncometabolite R-2-Hydroxygluta- rate-Induced Prostate Cancer Cell Invasion via Suppressing the circR-NA-51217/miRNA-646/TGFβ1/p-Smad2/3 Signaling. Cancer Letters, 472, 151-164. https://doi.org/10.1016/j.canlet.2019.12.014
|
[20]
|
Luo, Q., Wang, J., Zhao, W., et al. (2020) Vasculogenic Mimicry in Carcinogenesis and Clinical Applications. Journal of Hematology & Oncology, 13, Article No. 19. https://doi.org/10.1186/s13045-020-00858-6
|
[21]
|
Mao, X.G., Xue, X.Y., Wang, L., et al. (2013) CDH5 Is Specif-ically Activated in Glioblastoma Stemlike Cells and Contributes to Vasculogenic Mimicry Induced by Hypoxia. Neu-ro-Oncology, 15, 865.
https://doi.org/10.1093/neuonc/not029
|
[22]
|
Yue, W.-Y. and Chen, Z.-P. (2012) Vasculogenic Mimicry-Potential Target for Glioblastoma Therapy: An in vitro and in vivo Study. Medical Oncology, 29, 324-331. https://doi.org/10.1007/s12032-010-9765-z
|
[23]
|
Liu, Y., Lu, Y., Li, A., et al. (2020) mTORC2/Rac1 Pathway Pre-disposes Cancer Aggressiveness in IDH1-Mutated Glioma. Cancers, 12, 787. https://doi.org/10.3390/cancers12040787
|
[24]
|
Wang, S.Y., Ke, Y.Q., Lu, G.H., et al. (2013) Vasculogenic Mimic-ry Is a Prognostic Factor for Postoperative Survival in Patients with Glioblastoma. Journal of Neuro-Oncology, 112, 339-345. https://doi.org/10.1007/s11060-013-1077-7
|
[25]
|
Turcan, S., Makarov, V., Taranda, J., Wang, Y., Fabius, A.W.M., Wu, W., Zheng, Y., El-Amine, N., Haddock, S., Nanjangud, G., LeKaye, H.C., Brennan, C., Cross, J., Huse, J.T., Kelleher, N.L., Osten, P., Thompson, C.B. and Chan, T.A. (2018) Mutant-IDH1-Dependent Chromatin State Re-programming, Reversibility, and Persistence. Nature Genetics, 50, 62-72. https://doi.org/10.1038/s41588-017-0001-z
|